Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors within the central nervous technique, conolidine modulates alternate molecular targets. A Science Advances research observed that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://johno088msa1.blogolenta.com/profile